F11

Chr 4

coagulation factor XI

Also known as: FXI, PTA

This gene encodes coagulation factor XI of the blood coagulation cascade. This protein is present in plasma as a zymogen, which is a unique plasma coagulation enzyme because it exists as a homodimer consisting of two identical polypeptide chains linked by disulfide bonds. During activation of the plasma factor XI, an internal peptide bond is cleaved by factor XIIa (or XII) in each of the two chains, resulting in activated factor XIa, a serine protease composed of two heavy and two light chains held together by disulfide bonds. This activated plasma factor XI triggers the middle phase of the intrisic pathway of blood coagulation by activating factor IX. Defects in this factor lead to Rosenthal syndrome, a blood coagulation abnormality. [provided by RefSeq, Jul 2008]

GeneReviewsOMIMResearchGenerating clinical summary…
MultiplemechanismLOEUF 1.452 OMIM phenotypes
Clinical SummaryF11
🧬
Gene-Disease Validity (ClinGen)
congenital factor XI deficiency · SDDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
143 unique Pathogenic / Likely Pathogenic· 177 VUS of 638 total submissions
📖
GeneReview available — F11
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
1.45LOEUF
pLI 0.000
Z-score -0.53
OE 1.10 (0.841.45)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?
0.02Z-score
OE missense 1.00 (0.911.09)
342 obs / 343.0 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?1.10 (0.841.45)
00.351.4
Missense OE?1.00 (0.911.09)
00.61.4
Synonymous OE?1.05
01.21.6
LoF obs/exp: 37 / 33.7Missense obs/exp: 342 / 343.0Syn Z: -0.49

This gene — mechanism propensity

DN
0.6355th %ile
GOF
0.6639th %ile
LOF
0.3453th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). The Badonyi & Marsh model scores gain-of-function highest among its predictions, but genomic evidence (constraint, ClinVar variant spectrum, and literature) most strongly supports dominant-negative. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median · 1 literature citation
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Literature Evidence

DNThree dominant-negative mutations in factor XI-deficient patients1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

References

  1. 1.PMID 21457405

ClinVar Variant Classifications

638 submitted variants in ClinVar

Classification Summary

Pathogenic47
Likely Pathogenic96
VUS177
Likely Benign243
Benign42
Conflicting28
47
Pathogenic
96
Likely Pathogenic
177
VUS
243
Likely Benign
42
Benign
28
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
33
2
12
0
47
Likely Pathogenic
61
27
7
1
96
VUS
1
137
30
9
177
Likely Benign
1
6
102
134
243
Benign
0
1
39
2
42
Conflicting
28
Total96173190146633

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

43 pathogenic / likely-pathogenic (of 62) ClinVar copy-number / structural variants overlap F11 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

F11 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →